Maralixibat
MRX-802
Phase 3 small_molecule active
Quick answer
Maralixibat for Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC) is a Phase 3 program (small_molecule) at Mirum Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Mirum Pharmaceuticals
- Indication
- Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active